Publication:
Neurocognitive profiles of bipolar disorder patients receiving olanzapine or quetiapine in addition to mood-stabilizers

dc.contributor.coauthorErdogan, A.
dc.contributor.coauthorHidiroglu, C.
dc.contributor.coauthorOzerdem, A.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorCeylan, Deniz
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:42:23Z
dc.date.issued2021
dc.description.indexedbyWOS
dc.description.openaccessNO
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume53
dc.identifier.doi10.1016/j.euroneuro.2021.10.345
dc.identifier.eissn1873-7862
dc.identifier.issn0924-977X
dc.identifier.urihttps://doi.org/10.1016/j.euroneuro.2021.10.345
dc.identifier.urihttps://hdl.handle.net/20.500.14288/13309
dc.identifier.wos753359500335
dc.keywordsClinical neurology
dc.keywordsNeurosciences
dc.keywordsPharmacology and pharmacy
dc.keywordsPsychiatry
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofEuropean Neuropsychopharmacology
dc.subjectClinical neurology
dc.subjectNeurosciences
dc.subjectPharmacology
dc.subjectPharmacy
dc.subjectPsychiatry
dc.titleNeurocognitive profiles of bipolar disorder patients receiving olanzapine or quetiapine in addition to mood-stabilizers
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorÖzalp, Deniz Ceylan Tufan
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files